Literature DB >> 21134349

Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count.

Andreas Weiss1, Stephan Grueninger, Dorothée Abramowski, Francesco Paolo Di Giorgio, Miriam Moscovitch Lopatin, H Diana Rosas, Steven Hersch, Paolo Paganetti.   

Abstract

Huntington's disease is caused by a gain-of-function neurotoxic mutation in normally neuroprotective huntingtin. Sensitive assays are required to discriminate mutant huntingtin from wild-type huntingtin. We have developed a normalized 384-plate assay for determination of mutant and wild-type huntingtin. Based on a single pipetting step, the sensitive assay uses two antibody pairs for simultaneous mutant and wild-type huntingtin time-resolved fluorescence resonance energy transfer detection combined with PicoGreen quantification of double-stranded DNA. The assay can be used for discovery of drugs reducing mutant huntingtin over wild-type huntingtin and for assessing the value of huntingtin as a disease progression marker, and it is adaptable to other proteins of interest.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134349     DOI: 10.1016/j.ab.2010.11.044

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein.

Authors:  Barbara Baldo; Andreas Weiss; Christian N Parker; Miriam Bibel; Paolo Paganetti; Klemens Kaupmann
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

2.  Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.

Authors:  Weiqi Yang; Jingmo Xie; Qiang Qiang; Li Li; Xiang Lin; Yiqing Ren; Wenlei Ren; Qiong Liu; Guomin Zhou; Wenshi Wei; Hexige Saiyin; Lixiang Ma
Journal:  Neurosci Bull       Date:  2019-08-20       Impact factor: 5.203

3.  Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration.

Authors:  Barbara Calamini; Donald C Lo; Linda S Kaltenbach
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

4.  HTRF analysis of soluble huntingtin in PHAROS PBMCs.

Authors:  Miriam Moscovitch-Lopatin; Rachel E Goodman; Shirley Eberly; James J Ritch; H Diana Rosas; Samantha Matson; Wayne Matson; David Oakes; Anne B Young; Ira Shoulson; Steven M Hersch
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

5.  Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.

Authors:  David Marcellin; Dorothee Abramowski; Douglas Young; Jens Richter; Andreas Weiss; Audrey Marcel; Julia Maassen; Muriel Kauffmann; Miriam Bibel; Derya R Shimshek; Richard L M Faull; Gillian P Bates; Rainer R Kuhn; P Herman Van der Putten; Peter Schmid; Gregor P Lotz
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

6.  Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington Disease.

Authors:  Miriam Moscovitch-Lopatin; Andreas Weiss; Herminia Diana Rosas; James Ritch; Gheorghe Doros; Kimberly B Kegel; Marian Difiglia; Rainer Kuhn; Graeme Bilbe; Paolo Paganetti; Steven Hersch
Journal:  PLoS Curr       Date:  2010-12-29

7.  Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay.

Authors:  Barbara Baldo; Muhammad Umar Sajjad; Rachel Y Cheong; Julie Bigarreau; Ravi Vijayvargia; Catriona McLean; Anselme L Perrier; Ihn Sik Seong; Glenda Halliday; Åsa Petersén; Deniz Kirik
Journal:  eNeuro       Date:  2018-10-10

8.  Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.

Authors:  Andreas Weiss; Ulrike Träger; Edward J Wild; Stephan Grueninger; Ruth Farmer; Christian Landles; Rachael I Scahill; Nayana Lahiri; Salman Haider; Douglas Macdonald; Chris Frost; Gillian P Bates; Graeme Bilbe; Rainer Kuhn; Ralph Andre; Sarah J Tabrizi
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

9.  Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington's disease.

Authors:  Christian Landles; Andreas Weiss; Sophie Franklin; David Howland; Gill Bates
Journal:  PLoS Curr       Date:  2012-07-16

10.  Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.

Authors:  Luisa Massai; Lara Petricca; Letizia Magnoni; Luca Rovetini; Salman Haider; Ralph Andre; Sarah J Tabrizi; Sigurd D Süssmuth; Bernhard G Landwehrmeyer; Andrea Caricasole; Giuseppe Pollio; Simonetta Bernocco
Journal:  BMC Biochem       Date:  2013-11-25       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.